Fortgeschrittenes platinsensitives Ovarialkarzinom: Niraparib wirksam in allen Subgruppen
Crossref DOI link: https://doi.org/10.1007/s15015-018-4308-0
Published Online: 2018-11-05
Published Print: 2018-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bischoff, Angelika
Text and Data Mining valid from 2018-11-01
Article History
First Online: 5 November 2018